112 related articles for article (PubMed ID: 9871500)
1. A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity.
Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K
Amino Acids; 1998; 15(3):211-20. PubMed ID: 9871500
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of thrombin receptor-derived nonpeptide mimetics utilizing a piperazine scaffold.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Smith J; Mavromoustakos T; Saifeddine M; Moore G; Hollenberg M; Matsoukas J
Bioorg Med Chem; 1999 Jun; 7(6):1033-41. PubMed ID: 10428371
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.
Vassallo RR; Kieber-Emmons T; Cichowski K; Brass LF
J Biol Chem; 1992 Mar; 267(9):6081-5. PubMed ID: 1313429
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
[TBL] [Abstract][Full Text] [Related]
8. Development of potent thrombin receptor antagonist peptides.
Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
Lau LF; Pumiglia K; Côté YP; Feinstein MB
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1).
Nantermet PG; Barrow JC; Lundell GF; Pellicore JM; Rittle KE; Young M; Freidinger RM; Connolly TM; Condra C; Karczewski J; Bednar RA; Gaul SL; Gould RJ; Prendergast K; Selnick HG
Bioorg Med Chem Lett; 2002 Feb; 12(3):319-23. PubMed ID: 11814787
[TBL] [Abstract][Full Text] [Related]
11. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
Chao BH; Kalkunte S; Maraganore JM; Stone SR
Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
[TBL] [Abstract][Full Text] [Related]
12. Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif.
Hoekstra WJ; Hulshizer BL; McComsey DF; Andrade-Gordon P; Kauffman JA; Addo MF; Oksenberg D; Scarborough RM; Maryanoff BE
Bioorg Med Chem Lett; 1998 Jul; 8(13):1649-54. PubMed ID: 9873407
[TBL] [Abstract][Full Text] [Related]
13. 'Tethered ligand' derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for human platelet activation and GTPase stimulation.
Natarajan S; Riexinger D; Peluso M; Seiler SM
Int J Pept Protein Res; 1995 Feb; 45(2):145-51. PubMed ID: 7782162
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
15. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
[TBL] [Abstract][Full Text] [Related]
16. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
[TBL] [Abstract][Full Text] [Related]
17. Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides.
Hollenberg MD; Saifeddine M
Can J Physiol Pharmacol; 2001 May; 79(5):439-42. PubMed ID: 11405248
[TBL] [Abstract][Full Text] [Related]
18. A novel molecular design of thrombin receptor antagonist.
Fujita T; Nakajima M; Inoue Y; Nose T; Shimohigashi Y
Bioorg Med Chem Lett; 1999 May; 9(10):1351-6. PubMed ID: 10360734
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists.
Fujita T; Nose T; Nakajima M; Inoue Y; Costa T; Shimohigashi Y
J Biochem; 1999 Jul; 126(1):174-9. PubMed ID: 10393336
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of the thrombin receptor activating peptide.
Sabo T; Gurwitz D; Motola L; Brodt P; Barak R; Elhanaty E
Biochem Biophys Res Commun; 1992 Oct; 188(2):604-10. PubMed ID: 1332704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
